High prevalence of the CD14-159CC genotype in patients infected with severe acute respiratory syndrome-associated coronavirus
- PMID: 17913858
- PMCID: PMC2168372
- DOI: 10.1128/CVI.00100-07
High prevalence of the CD14-159CC genotype in patients infected with severe acute respiratory syndrome-associated coronavirus
Abstract
To investigate whether genetic factors of innate immunity might influence susceptibility and/or progression in individuals infected with SARS, we evaluated the CD14 gene polymorphism in 198 Hong Kong blood donors and 152 Hong Kong severe acute respiratory syndrome (SARS) patients who were previously genotyped for FcgammaRIIA polymorphisms. The prevalence of the CD14-159CC polymorphism was significantly higher in the patients with severe SARS than in the those with mild SARS or controls (31% versus 15% [mild SARS] or 20% [controls]; mild SARS: P = 0.029; odds ratio, 2.74; 95% confidence interval, 1.15 to 6.57; controls, P = 0.04; odds ratio, 2.41; 95% confidence interval, 1.05 to 5.54), and both CD14-159CC and FcgammaRIIA-RR131 are risk genotypes for severe SARS-CoV infection.
Similar articles
-
Influence of FcgammaRIIA and MBL polymorphisms on severe acute respiratory syndrome.Tissue Antigens. 2005 Oct;66(4):291-6. doi: 10.1111/j.1399-0039.2005.00476.x. Tissue Antigens. 2005. PMID: 16185324 Free PMC article.
-
The association of RANTES polymorphism with severe acute respiratory syndrome in Hong Kong and Beijing Chinese.BMC Infect Dis. 2007 Jun 1;7:50. doi: 10.1186/1471-2334-7-50. BMC Infect Dis. 2007. PMID: 17540042 Free PMC article.
-
Clinical relevance of TLR2, TLR4, CD14 and FcgammaRIIA gene polymorphisms in Streptococcus pneumoniae infection.Immunol Cell Biol. 2008 Mar-Apr;86(3):268-70. doi: 10.1038/sj.icb.7100155. Epub 2008 Jan 8. Immunol Cell Biol. 2008. PMID: 18180796
-
Epidemiology of severe acute respiratory syndrome (SARS): adults and children.Paediatr Respir Rev. 2004 Dec;5(4):270-4. doi: 10.1016/j.prrv.2004.07.011. Paediatr Respir Rev. 2004. PMID: 15531250 Free PMC article. Review.
-
T cell-mediated immune response to respiratory coronaviruses.Immunol Res. 2014 Aug;59(1-3):118-28. doi: 10.1007/s12026-014-8534-z. Immunol Res. 2014. PMID: 24845462 Free PMC article. Review.
Cited by
-
Genetic variants of the human host influencing the coronavirus-associated phenotypes (SARS, MERS and COVID-19): rapid systematic review and field synopsis.Hum Genomics. 2020 Sep 11;14(1):30. doi: 10.1186/s40246-020-00280-6. Hum Genomics. 2020. PMID: 32917282 Free PMC article.
-
SARS-CoV-2 and COVID-19: A genetic, epidemiological, and evolutionary perspective.Infect Genet Evol. 2020 Oct;84:104384. doi: 10.1016/j.meegid.2020.104384. Epub 2020 May 29. Infect Genet Evol. 2020. PMID: 32473976 Free PMC article. Review.
-
Host variations in SARS-CoV-2 infection.Turk J Biol. 2021 Aug 30;45(4):404-424. doi: 10.3906/biy-2104-67. eCollection 2021. Turk J Biol. 2021. PMID: 34803443 Free PMC article. Review.
-
Genetic Risk Factors for the Development of COVID-19 Coronavirus Infection.Russ J Genet. 2021;57(8):878-892. doi: 10.1134/S1022795421080056. Epub 2021 Aug 30. Russ J Genet. 2021. PMID: 34483599 Free PMC article.
-
Cellular and Molecular Pathways of COVID-19 and Potential Points of Therapeutic Intervention.Front Pharmacol. 2020 Jul 29;11:1169. doi: 10.3389/fphar.2020.01169. eCollection 2020. Front Pharmacol. 2020. PMID: 32848776 Free PMC article.
References
-
- Arbour, N. C., E. Lorenz, B. C. Schutte, J. Zabner, J. N. Kline, M. Jones, K. Frees, J. L. Watt, and D. A. Schwartz. 2000. TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat. Genet. 25:187-191. - PubMed
-
- Baldini, M., I. C. Lohman, M. Halonen, R. P. Erickson, P. G. Holt, and F. D. Martinez. 1999. A polymorphism in the 5′ flanking region of the CD14 gene is associated with circulating soluble CD14 levels and with total serum immunoglobulin E. Am. J. Respir. Cell Mol. Biol. 20:976-983. - PubMed
-
- Kabesch, M., K. Hasemann, V. Schickinger, I. Tzotcheva, A. Bohnert, D. Carr, M. Baldini, H. Hackstein, W. Leupold, S. K. Weiland, F. D. Martinez, E. Mutius, and G. Bein. 2004. A promoter polymorphism in the CD14 gene is associated with elevated levels of soluble CD14 but not with IgE or atopic diseases. Allergy 59:520-525. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous